Research of Efficacy and Safety of Botulinum Toxin Type A Combined with Compound Betamethasone Injection in Treatment of Patients with Keloid
Jia-wen WU,Jing-yi YUAN,Jing LIU,Jun ZHOU,Rui-lian LI,Yuan WANG,Shuang WANG
DOI: https://doi.org/10.13241/j.cnki.pmb.2018.23.008
2018-01-01
Abstract:Objective: To analyze the efficacy and safety of botulinum toxin type A combined with compound betamethasone injection in treatment of patients with keloid. Methods: 90 patients with keloid who were treated in our hospital from January 2015 to August 2016 were selected as the research object, and they were randomly divided into A group, B group and C group according to different of treatment methods, 30 cases in each group. The A group were treated with botulinum toxin type A, the B group were treated with compound betamethasone injection and the C group were treated with botulinum toxin type A combined with compound betamethasone injection. Related indexes improvement score, clinical efficacy, the incidence of adverse reaction and the recurrence rate were compared between three groups. Results: The improvement score of keloid volume, hardness, pain/itching sensation and self-evaluation of patients in C group were higher than those in B group and A group (P＜0.05). There was no statistical difference in improvement score of various indexes between the B group and the A group (P＞0.05). The total effective rate of the three groups was statistically significant,and the C group was higher than that of the B group (P＜0.05). There was no significant difference in the total effective rate between the A group and the C group (P＞0.05). The total incidence of adverse reactions in A group was lower than those in B group and C group, the difference was statistically significant (P＜0.05), while there was no difference between B group and C group (P＞0.05). The recurrence rate of keloid in A group and C group was lower than that in B group at half a year and 1 years after treatment(P＜0.05), but there was no significant difference between A group and C group (P＞0.05). Conclusion: Compared with the use of botulinum toxin type A or compound betamethasone injection alone, the combined use of botulinum toxin type A and compound betamethasone injection in the treatment of keloid can significantly improve the efficacy, reduce the recurrence rate, and it does not increase the incidence of adverse reactions, safety is high, which is worthy of further application.